TrialJournal of the American Heart Association2026

Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial.

Sushil Allen Luis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.